medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2021-3-128-134medsovet-6083Research ArticleПРЕ- И ПОСТМЕНОПАУЗАPRE- AND POSTMENOPAUSEАнемия возрастных пациенток. Рациональная профилактика. Доказательная базаAnemia in elderly women. Rational prevention. Evidence basehttps://orcid.org/0000-0002-9491-9303МарковаЭ. А.MarkovaE. A.

Маркова Элеонора Александровна - кандидат медицинских наук, ассистент кафедры акушерства и гинекологии.

117997, Москва, ул. Островитянова

Eleonora A. Markova - Cand. Sci. (Med.), Teaching Assistant of Department of Obstetrics and Gynaecology.

1, Ostrovityanov St., Moscow, 117997

markova.eleonora@mail.ruhttps://orcid.org/0000-0001-7591-6281ХашукоеваА. З.KhashukoevaA. Z.

Хашукоева Асият Зульчифовна - доктор медицинских наук, профессор кафедры акушерства и гинекологии.

117997, Москва, ул. Островитянова, д. 1

Asiyat Z. Khashukoeva - Dr. Sci. (Med.), Professor of Department of Obstetrics and Gynaecology.

1, Ostrovityanov St., Moscow, 117997

azk05@mail.ruhttps://orcid.org/0000-0003-1554-3633ХлыноваС. А.KhlynovaS. A.

Хлынова Светлана Анатольевна - кандидат медицинских наук, доцент кафедры акушерства и гинекологии.

117997, Москва, ул. Островитянова, д. 1

Svetlana A. Khlynova - Cand. Sci. (Med.), Assistant Professor of Department of Obstetrics and Gynaecology.

1, Ostrovityanov St., Moscow, 117997

doc-khlinova@mail.ruhttps://orcid.org/0000-0002-0304-4901БурденкоМ. В.BurdenkoM. V.

Бурденко Марина Владимировна - кандидат медицинских наук, доцент кафедры акушерства и гинекологии, заместитель декана.

117997, Москва, ул. Островитянова, д. 1

Marina V. Burdenko, Cand. Sci. (Med.), Assistant Professor of Department of Obstetrics and Gynaecology.

1, Ostrovityanov St., Moscow, 117997

bmv-0306@rambler.ruhttps://orcid.org/0000-0003-3410-2059КаранашеваА. Х.KaranashevaA. Kh.

Каранашева Альбина Хасанбиевна - кандидат медицинских наук, ассистент кафедры акушерства и гинекологии.

117997, Москва, ул. Островитянова, д. 1

Albina Kh. Karanasheva, Cand. Sci. (Med.), Teaching Assistant of Department of Obstetrics and Gynaecology.

1, Ostrovityanov St., Moscow, 117997

kar.albina@gmail.comРоссийский национальный исследовательский медицинский университет им. Н.И. ПироговаРоссияPirogov Russian National Research Medical UniversityRussian Federation20211504202103128134Copyright © Маркова Э.А., Хашукоева А.З., Хлынова С.А., Бурденко М.В., Каранашева А.Х., 20212021Маркова Э.А., Хашукоева А.З., Хлынова С.А., Бурденко М.В., Каранашева А.Х.Markova E.A., Khashukoeva A.Z., Khlynova S.A., Burdenko M.V., Karanasheva A.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/6083

Железодефицитная анемия - частый спутник у женщин в постменопаузальном периоде и достигших зрелого возраста. Анемия в легкой форме у немолодых женщин часто протекает практически бессимптомно. С течением времени дефицит железа прогрессирует: возникают тяжелые осложнения, значительно снижается качество жизни и прогноз становится неблагоприятным. Срез литературных данных за последние годы показывает, что на первый план по этиологическим факторам анемии у женщин преклонного возраста выходят дефицит железа, фолатов, витамина В12, заболевания желудочно-кишечного тракта, патологии в процессах эритропоэза и другие соматические заболевания. Немаловажное значение в развитии анемии у немолодых женщин играет нерациональное питание в течение всей жизни, что обусловливает недостаток железа и фолатов в пище.

Именно поэтому терапия комплексным препаратом, в состав которого входят железа (II) фумарат в сочетании с фолиевой кислотой, является рациональным выбором в сравнении с монопрепаратами железа для профилактики и лечения анемии у женщин почтенного возраста. Назначение пероральных препаратов железа для коррекции его дефицита и с целью подбора эффективной патогенетической терапии анемии решает вопрос осложнений и улучшает качество жизни женщин преклонного возраста. Железа (II) фумарат + фолиевая кислота - таблетированная форма препарата железа в комплексе с фолиевой кислотой для перорального применения, который обладает хорошей переносимостью, быстро восполняет запасы железа в организме немолодых пациенток, снижая летальность в данной возрастной группе.

Iron deficiency anemia is a frequent companion in postmenopausal women and those who have reached adulthood. Anemia in mild form in elderly women often occurs almost asymptomatically. Over time, iron deficiency progresses: severe complications occur, the quality of life decreases significantly, and the prognosis for life becomes unfavorable. A cross-section of the literature data in recent years shows that iron, folate, vitamin B12 deficiency, gastrointestinal diseases, pathologies in the processes of erythropoiesis and other somatic diseases come to the fore in terms of the etiological factors of anemia in elderly women. An important role in the development of anemia in older women is played by an irrational diet throughout life, which causes a lack of iron and folate in food. That is why therapy with a complex drug, which includes iron (II) fumarate in combination with folic acid is a rational choice in comparison with iron monotherapy for the prevention and treatment of anemia in elderly women. The administration of oral iron preparations for the correction of iron deficiency and for the purpose of selecting an effective pathogenetic therapy for anemia solves the problem of complications and improves the quality of life of older women. Iron (II) fumarate + folic acid - a tablet form of iron preparation in combination with folic acid for oral use, which has good tolerability, quickly replenishes iron reserves in the body of elderly patients, reducing mortality in this age group.

железа (II) фумаратжелезодефицитная анемиядефицит железапациенты пожилого и старческого возрастаанемияпостменопаузаiron (II) fumarateiron deficiency anemiairon deficiencyelderly and senile patientspostmenopausal anemiaReferencesHelsen T., Joosten E. Iron deficiency in the elderly. Tijdschr Gerontol Geriatr. 2016;47(3):109-116. (In Dutch) doi: 10.1007/s12439-016-0171-7.Helsen T., Joosten E. Iron deficiency in the elderly. Tijdschr Gerontol Geriatr. 2016;47(3):109-116. (In Dutch) doi: 10.1007/s12439-016-0171-7.Manckoundia P., Konate A., Hacqui A., Nuss V., Mihai A.M., Vovelle J. et al. Iron in the general population and specificities in older adults: metabolism, causes and consequences of decrease or overload, and biological assessment. Clin IntervAging. 2020;15:1927-1938. doi: 10.2147/CIA.S269379.Manckoundia P., Konate A., Hacqui A., Nuss V., Mihai A.M., Vovelle J. et al. Iron in the general population and specificities in older adults: metabolism, causes and consequences of decrease or overload, and biological assessment. Clin Interv Aging. 2020;15:1927-1938. doi: 10.2147/CIA.S269379.World Health Organization. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers. Geneva: World Health Organization; 2001. Available at: https://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf.World Health Organization. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers. Geneva: World Health Organization; 2001. Available at: https://www.who.int/nutrition/publica-tions/en/ida_assessment_prevention_control.pdf.Mirza F.G., Abdul-Kadir R., Breymann C., Fraser I.S., Taher A. Impact and management of iron deficiency and iron deficiency anemia in women's health. Expert RevHematol. 2018;11(9):727-736. doi: 10.1080/17474086.2018.1502081.Mirza F.G., Abdul-Kadir R., Breymann C., Fraser I.S., Taher A. Impact and management of iron deficiency and iron deficiency anemia in women's health. Expert RevHematol. 2018;11(9):727-736. doi: 10.1080/17474086.2018.1502081.Auerbach M., Adamson J.W. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):67-74. doi: 10.1002/ajh.24201.Auerbach M., Adamson J.W. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):67-74. doi: 10.1002/ajh.24201.Gozzelino R., Arosio P. Iron homeostasis in health and disease. Int J Mol Sci. 2016;17(1):130. doi: 10.3390/ijms17010130.Gozzelino R., Arosio P. Iron homeostasis in health and disease. Int J Mol Sci. 2016;17(1):130. doi: 10.3390/ijms17010130.DeLoughery T.G. Iron Deficiency Anemia. Med Clin North Am. 2017;101(2):319-332. doi: 10.1016/j.mcna.2016.09.004.DeLoughery T.G. Iron Deficiency Anemia. Med Clin North Am. 2017;101(2):319-332. doi: 10.1016/j.mcna.2016.09.004.Wawer A.A., Jennings A., Fairweather-Tait SJ. Iron status in the elderly: A review of recent evidence. Mech Ageing Dev. 2018;175:55-73. doi: 10.1016/j.mad.2018.07.003.Wawer A.A., Jennings A., Fairweather-Tait SJ. Iron status in the elderly: A review of recent evidence. Mech Ageing Dev. 2018;175:55-73. doi: 10.1016/j.mad.2018.07.003.Manckoundia P., Barben J., Asgassou S., Putot A., Konate A. Iron deficiency in adults: to understand what biological evaluation should be carried out. Rev Med Liege. 2020;75(12):791-796. (In French). Available at: https://pubmed.ncbi.nlm.nih.gov/33331703/.Manckoundia P., Barben J., Asgassou S., Putot A., Konate A. Iron deficiency in adults: to understand what biological evaluation should be carried out. Rev Med Liege. 2020;75(12):791-796. (In French). Available at: https://pubmed.ncbi.nlm.nih.gov/33331703/.Randi M.R., Bertozzi I., Santarossa C., Cosi E., Lucente F., Bogoni G. et al. Prevalence and causes of anemia in hospitalized patients: impact on diseases outcome. J Clin Med. 2020;9(4):950. doi: 10.3390/jcm9040950.Randi M.R., Bertozzi I., Santarossa C., Cosi E., Lucente F., Bogoni G. et al. Prevalence and causes of anemia in hospitalized patients: impact on diseases outcome. J Clin Med. 2020;9(4):950. doi: 10.3390/jcm9040950.Громова О.А., Торшин И.Ю., Хаджидис А.К. Анализ молекулярных механизмов воздействия железа (iI), меди, марганца в патогенезе железодефицитной анемии. Клиническая фармакология и фармакоэкономика. 2010;3(1):30-37. Режим доступа: https://medi.ru/info/5757/.Gromova O.A., Torshin I.Yu., Khadzhidis A.K. Analysis of the molecular mechanisms of the effects of iron (iI), copper, manganese against iron deficiency anemia pathogenesis. Klinicheskaya farmakologiya i farmakoe-hkonomika = Clinical Pharmacology and Pharmacoeconomics. 2010;3(1): 30-37. (In Russ.) Available at: https://medi.ru/info/5757/.Gargallo-Puyuelo CJ., Alfambra E., Garcia-Erce J.A., Gomollon F. Iron Treatment may be difficult in inflammatory diseases: inflammatory bowel disease as a paradigm. Nutrients. 2018;10(12):1959. doi: 10.3390/nu10121959.Gargallo-Puyuelo C.J., Alfambra E., Garcia-Erce J.A., Gomollon F. Iron Treatment may be difficult in inflammatory diseases: inflammatory bowel disease as a paradigm. Nutrients. 2018;10(12):1959. doi: 10.3390/nu10121959.Auerbach M., Spivak J. Treatment of iron deficiency in the elderly: a new paradigm. Clin Geriatr Med. 2019;35(3):307-317. doi: 10.1016/j.cger.2019.03.003.Auerbach M., Spivak J. Treatment of iron deficiency in the elderly: a new paradigm. Clin Geriatr Med. 2019;35(3):307-317. doi: 10.1016/j.cger.2019.03.003.Kohgo Y., Ikuta K., Ohtake T., Torimoto Y., Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88(1):7-15. doi: 10.1007/s12185-008-0120-5.Kohgo Y., Ikuta K., Ohtake T., Torimoto Y., Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88(1):7-15. doi: 10.1007/s12185-008-0120-5.Romano A.D., Paglia A., Bellanti F., Villani R., Sangineto M., Vendemiale G., Serviddio G. Molecular aspects and treatment of iron deficiency in the elderly. Int J Mol Sci. 2020;21(11):3821. doi: 10.3390/ijms21113821.Romano A.D., Paglia A., Bellanti F., Villani R., Sangineto M., Vendemiale G., Serviddio G. Molecular aspects and treatment of iron deficiency in the elderly. Int J Mol Sci. 2020;21(11):3821. doi: 10.3390/ijms21113821.Akpinar H., Qetiner M., Keshav S., Ormeci N., Toruner M. Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report. Turk J Gastroenterol. 2017;28(2):81-87. doi: 10.5152/tjg.2017.17593.Akpinar H., Qetiner M., Keshav S., Ormeci N., Toruner M. Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report. Turk J Gastroenterol. 2017;28(2):81-87. doi: 10.5152/tjg.2017.17593.Lanier J.B., Park JJ., Callahan R.C. Anemia in older adults. Am Fam Physician. 2018;98(7):437-442. Available at: https://pubmed.ncbi.nlm.nih.gov/30252420/.Lanier J.B., Park JJ., Callahan R.C. Anemia in older adults. Am Fam Physician. 2018;98(7):437-442. Available at: https://pubmed.ncbi.nlm.nih.gov/30252420/.Chueh H.W., Jung H.L., Shim YJ., Choi H.S., Han J.Y. High anemia prevalence in Korean older adults, an advent healthcare problem: 2007-2016 KNHANES. BMC Geriatr. 2020;20(1):509. doi: 10.1186/s12877-020-01918-9.Chueh H.W., Jung H.L., Shim YJ., Choi H.S., Han J.Y. High anemia prevalence in Korean older adults, an advent healthcare problem: 2007-2016 KNHANES. BMC Geriatr. 2020;20(1):509. doi: 10.1186/s12877-020-01918-9.Stauder R., Bach V., Schruckmayr G., Sam I., Kemmler G., Stauder R. Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort. Clin Interv Aging. 2014;9:1187. doi: 10.2147/CIA.S61125.Stauder R., Bach V., Schruckmayr G., Sam I., Kemmler G., Stauder R. Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort. Clin Interv Aging. 2014;9:1187. doi: 10.2147/CIA.S61125.Cuskelly GJ., Mooney K.M., Young I.S. Folate and vitamin B12: friendly or enemy nutrients for the elderly. Proc Nutr Soc. 2007;66(4):548-558. doi: 10.1017/S0029665107005873.Cuskelly GJ., Mooney K.M., Young I.S. Folate and vitamin B12: friendly or enemy nutrients for the elderly. Proc Nutr Soc. 2007;66(4):548-558. doi: 10.1017/S0029665107005873.Halawi R., Moukhadder H., Taher A. Anemia in the elderly: a consequence of aging? Expert Rev Hematol. 2017;10(4):327-335. doi: 10.1080/17474086.2017.1285695.Halawi R., Moukhadder H., Taher A. Anemia in the elderly: a consequence of aging? Expert Rev Hematol. 2017;10(4):327-335. doi: 10.1080/17474086.2017.1285695.Hahn D., Esezobor C.I., Elserafy N., Webster A.C., Hodson E.M. Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients. Cochrane Database Syst Rev. 2017;1(1):CD011690. doi: 10.1002/14651858.CD011690.pub2.Hahn D., Esezobor C.I., Elserafy N., Webster A.C., Hodson E.M. Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients. Cochrane Database Syst Rev. 2017;1(1):CD011690. doi: 10.1002/14651858.CD011690.pub2.Provenzano R., Besarab A., Wright S., Dua S., Zeig S., Nguyen P et al. Roxadustat (FG-4592) versus epoetin alfa for anemia in patients receiving maintenance hemodialysis: a phase 2, randomized, 6- to 19-Week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study. Am J Kidney Dis. 2016;67(6):912-924. doi: 10.1053/j.ajkd.2015.12.020.Provenzano R., Besarab A., Wright S., Dua S., Zeig S., Nguyen P et al. Roxadustat (FG-4592) versus epoetin alfa for anemia in patients receiving maintenance hemodialysis: a phase 2, randomized, 6- to 19-Week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study. Am J Kidney Dis. 2016;67(6):912-924. doi: 10.1053/j.ajkd.2015.12.020.Daru J., Colman K., Stanworth SJ., De La Salle B., Wood E.M., Pasricha S.R. Serum ferritin as an indicator of iron status: what do we need to know? Am J Clin Nutr. 2017;106(Suppl 6):1634S-1639S. doi: 10.3945/ajcn.117.155960.Daru J., Colman K., Stanworth SJ., De La Salle B., Wood E.M., Pasricha S.R. Serum ferritin as an indicator of iron status: what do we need to know? Am J Clin Nutr. 2017;106(Suppl 6):1634S-1639S. doi: 10.3945/ajcn.117.155960.De Franceschi L., Iolascon A., Taher A., Cappellini M.D. Clinical management of iron deficiency anemia in adults: Systemic review on advances in diagnosis and treatment. Eur J Intern Med. 2017;42:16-23. doi: 10.1016/j.ejim.2017.04.018.De Franceschi L., Iolascon A., Taher A., Cappellini M.D. Clinical management of iron deficiency anemia in adults: Systemic review on advances in diagnosis and treatment. Eur J Intern Med. 2017;42:16-23. doi: 10.1016/j.ejim.2017.04.018.Gomez Ramirez S., Remacha Sevilla A.F., Munoz Gomez M. Anaemia in the elderly. Med Clin (Barc). 2017;149(11):496-503. doi: 10.1016/j.medcli.2017.06.025.Gomez Ramirez S., Remacha Sevilla A.F., Munoz Gomez M. Anaemia in the elderly. Med Clin (Barc). 2017;149(11):496-503. doi: 10.1016/j.medcli.2017.06.025.Righetti M. Folate metabolism dysfunction. G Ital Nefrol. 2008;25(1):32-41. (In Italian) Available at: https://pubmed.ncbi.nlm.nih.gov/18264916/.Righetti M. Folate metabolism dysfunction. G Ital Nefrol. 2008;25(1): 32-41. (In Italian) Available at: https://pubmed.ncbi.nlm.nih.gov/18264916/Allen L.H. Causes of vitamin B12 and folate deficiency. Food Nutr Bull. 2008;29(2S):S20-34. doi: 10.1177/15648265080292S105.Allen L.H. Causes of vitamin B12 and folate deficiency. Food Nutr Bull. 2008;29(2S):S20-34. doi: 10.1177/15648265080292S105.Rohrig G. Anemia in the frail, elderly patient. Clin IntervAging. 2016;11:319-326. doi: 10.2147/CIA.S90727.Rohrig G. Anemia in the frail, elderly patient. Clin Inter/Aging. 2016;11:319-326. doi: 10.2147/CIA.S90727.Torshin I.Yu. Sensing the Change: From Molecular Genetics to Personalized Medicine (Bioinformatics in the Post-genomic Era). New York: Nova Science; 2009. 366 p.Torshin I.Yu. Sensing the Change: From Molecular Genetics to Personalized Medicine (Bioinformatics in the Post-genomic Era). New York: Nova Science; 2009. 366 p.Okam M.M., Koch T.A., Tran M.H. Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials. Haematologica. 2016;101(1):e6-e7. doi: 10.3324/haematol.2015.129114.Okam M.M., Koch T.A., Tran M.H. Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials. Haematologica. 2016;101(1):e6-e7. doi: 10.3324/haematol.2015.129114.Байжанова К.Т., Темиркулова Ш.А., Садырханова ПЖ. Сравнительная оценка эффективности пероральных препаратов железа при железодефицитной анемии. Евразийский Союз ученых. 2015;(3):46-48. Режим доступа: https://euroasia-science.ru/medicinskie-nauki/сравнительная-оценка-эффективности/.Bayzhanova K.T., Temirkulova Sh.A., Sadyrkhanova G.Zh. Comparative evaluation of efficacy of oral iron supplements in iron deficiency anemia. Evraziyskiy Soyuz uchenykh = Eurasian Union of Scientists. 2015;(3):46-48. (In Russ.) Available at: https://euroasia-science.ru/medicinskie-nauki/сравнительная-оценка-эффективности/.Santiago P Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. Scientific World Journal. 2012;2012:846824. doi: 10.1100/2012/846824.Santiago P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. Scientific World Journal. 2012;2012:846824. doi: 10.1100/2012/846824.Okam M.M., Koch T.A., Tran M.H. Iron supplementation, response in iron-deficiency anemia: analysis of five trials. Am J Med. 2017;130(8):991. e1-991.e8. doi: 10.1016/j.amjmed.2017.03.045.Okam M.M., Koch T.A., Tran M.H. Iron supplementation, response in iron-DEFICIENCY anemia: analysis of five trials. Am J Med. 2017;130(8):991. e1-991.e8. doi: 10.1016/j.amjmed.2017.03.045.Хашукоева А.З., Агаева М.И., Дугиева М.З., Сухова Т.Н., Абдурахманова Л.И. Современные подходы к лечению железодефицитной анемии у больных с гинекологической патологией. Лечащий врач. 2017;(12): 23-27. Режим доступа: https://www.lvrach.ru/2017/12/15436863.Khachukoeva A.Z., Agaeva M.I., Dugieva M.Z., Sukhova T.N., Abdurakhmanova L.I. Modern approaches to treatment of iron-deficiency anemia in patients with gynecological pathology. Lechaschi Vrach Journal. 2017;(12):23-27. (In Russ.) Available at: https://www.lvrach.ru/2017/ 12/15436863.Румянцев А.П., Масчан А.А. Федеральные клинические рекомендации по диагностике и лечению железодефицитной анемии. М.; 2014. 16 с. Режим доступа:https://nodgo.org/sites/default/ФКР%20по%20диагностике%20и%20лечению%20железодефицитной%20анемии.pdf.Rumyantsev A.G., Maschan A.A. Federal clinical recommendations for the diagnosis and treatment of iron-deficient anemia. Moscow; 2014.Приншпун Л.Д., Пивник А.В. (ред.). Гериатрическая гематология. Заболевания системы крови в старших возрастных группах. Т. 2. М.: Медиум; 2012. 728 с.Grinshpun L.D., Pivnik A.V. (eds.) Geriatric hematology. Diseases of the blood system in older age groups. Moscow: Medium; 2012. Vol. 2, 728 р. (In Russ.).

The authors declare that there are no conflicts of interest present.